Trends in Insulin Types and Devices Used by Adults With Type 2 Diabetes in the United States, 2016 to 2020

Correlates of analog vs human basal insulin use among individuals with type 2 diabetes: A cross-sectional study

(2021) Sara J. Cromer et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Origins of the Crisis in Insulin Affordability and Practical Advice for Clinicians on Using Human Insulin

(2020) Jing Luo et al.   Current Diabetes Reports

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2020 EXECUTIVE SUMMARY

(2020) Alan J. Garber et al.   Endocrine Practice

Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey

(2020) Phuc Le et al.   DIABETES CARE

Trends in Insulin Out-of-Pocket Costs and Reimbursement Price Among US Patients With Private Health Insurance, 2006-2017

(2020) Amir Meiri et al.   JAMA Internal Medicine

Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020

(2020) Mark É. Czeisler et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018

(2019) Inmaculada Hernandez et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis

(2019) Kerry Mansell et al.   BMC HEALTH SERVICES RESEARCH

Insulin Access and Affordability Working Group: Conclusions and Recommendations

(2018) William T. Cefalu et al.   DIABETES CARE

Unknown

(2018)   DIABETES OBESITY & METABOLISM

Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes

(2018) Kasia J. Lipska et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review

(2018) Carolyn Tieu et al.   PLoS One

Human Insulin for Type 2 Diabetes

(2017) Kasia J. Lipska et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney DiseaseCLINICAL PERSPECTIVE

(2016) Priyesh A. Patel et al.   Circulation-Heart Failure

Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013

(2016) Xinyang Hua et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Constraints and challenges in access to insulin: a global perspective

(2016) David Beran et al.   Lancet Diabetes & Endocrinology

Insulin Analogs—Are They Worth It? Yes!

(2014) George Grunberger   DIABETES CARE

Use and Out-of-Pocket Costs of Insulin for Type 2 Diabetes Mellitus From 2000 Through 2010

(2014) Kasia J. Lipska et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012

(2013) Lydia W. Turner et al.   DIABETES CARE

The insulin dilemma in resource-limited countries. A way forward?

(2010) G. V. Gill et al.   DIABETOLOGIA